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Abstract
Growing evidences indicate that Ly-GDI, an inhibitory protein of Rho GTPases, plays an
essential role in regulating actin cytoskeletal alteration which is indispensible for the pro-
cess such as phagocytosis. However, the role of Ly-GDI in inflammation remains largely
unknown. In the current study, we found that Ly-GDI expression was significantly
decreased in the IgG immune complex-injured lungs. To determine if Ly-GDI might regulate
the lung inflammatory response, we constructed adenovirus vectors that could mediate
ectopic expression of Ly-GDI (Adeno-Ly-GDI). In vivomouse lung expression of Ly-GDI
resulted in a significant attenuation of IgG immune complex-induced lung injury, which was
due to the decreased pulmonary permeability and lung inflammatory cells, especially neu-
trophil accumulation. Upon IgG immune complex deposition, mice with Ly-GDI over-expres-
sion in the lungs produced significant less inflammatory mediators (TNF-α, IL-6, MCP-1,
and MIP-1α) in bronchoalveolar lavage fluid when compared control mice receiving airway
injection of Adeno-GFP. Mechanically, IgG immune complex-induced NF-κB activity was
markedly suppressed by Ly-GDI in both alveolar macrophages and lungs as measured by
luciferase assay and electrophoretic mobility shift assay. These findings suggest that Ly-
GDI is a critical regulator of inflammatory injury after deposition of IgG immune complexes
and that it negatively regulates the lung NF-κB activity.
Introduction
Ly-GDI, also known as D4-GDI, RhoGDI2, GDID4 or RhoGDIB, is a member of Rho guani-
dine dissociation inhibitor (RhoGDI) family that is composed of three members-RhoGDIα,
RhoGDI2, and RhoGDI3 [1, 2]. RhoGDI could keep the small signal proteins, RhoGTPases, in
their cytosolic inactive state by interacting with the RhoGTPases’ isoprenyl motif located in C-
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terminal hydrophobic pocket and suppressing dissociation of bound GDP from RhoGTPases
[1–3]. When dissociated from RhoGDI and GDP, RhoGTPases become active form by binding
to GTP and relocate to plasma membrane through the C-terminal isoprenyl motif [1, 4]. In
vitro studies have demonstrated that Cdc42, RhoA, and Rac might be potential substrates of
Ly-GDI [5]. The roles of RhoGDI in processes involved in cytoskeletal changes have been
investigated. For example, ectopic expression of Ly-GDI blocks the cytoskeletal change, which
might results in disruption of Rac-stimulated phagocytosis [6]. In T cells, Ly-GDI functions
cooperatively with the GDP/GTP exchange factors (GEF), Vav1, as signal transducers in the T
cell receptor (TCR) pathway, which lead to the cytoskeletal reorganization required for the
immunological synapse formation [7]. Consistent with these results, a recent study finds that
Ly-GDI inhibits Fcγ receptor (FcγR)-mediated phagocytosis by suppressing association of Rac
with plasma membrane in human monocytes [1]. However, the impact of Ly-GDI on inflam-
mation including the FcγR activation-induced inflammatory responses remains unknown.
IgG immune complex (IC)-induced activation of immune cells could lead to a variety of
autoimmune diseases including immune thrombocytopenia, systemic lupus erythematosus,
extrinsic allergic alveolitis, and rheumatoid arthritis [8–11]. IgG IC exerts its inflammatory
effect by association of its Fc portion with the FcγRs. FcγRs are also involved in antibody
dependent control of certain bacterial and viral infections in human and mice [12]. Several
mechanisms including antibody-dependent cell-mediated cytotoxicity (ADCC), phaocytosis,
and release of inflammatory mediators are involved in the pathogen clearance mediated by the
interaction between pathogen-bound IgG and FcγRs [9, 13]. IgG IC-induced acute lung injury
(ALI) in rodent has been used to investigate the molecular mechanisms involved in FcγR-
mediated inflammatory reactions in vivo [14–16]. In this model, airway depositionof IgG IC
stimulates alveolar macrophage to synthesize and release early response cytokines, such as
TNF-α [17, 18]. The early responsive cytokines then induce various chemokine production,
and the subsequent formation of chemoattractant gradients that accelerate transmigration of
neutrophils from vascular vessels into lungs [19]. Activated macrophages and neutrophils
release toxic reactive oxygen species (ROS) and proteases into lungs, leading to damages of pul-
monary parenchyma [20] [21, 22]. The end results are elevated pulmonary microvascular per-
meability, intrapulmonary hemorrhage, and accumulation of protein rich edema fluid and
fibrin. However, the signaling pathways that counter-regulate the inflammatory responses in
IgG IC-injured lung remain largely unknown. In the current study, we evaluate the effect of
Ly-GDI on IgG IC-induced ALI. By using adenovirus-mediated ectopic expression of Ly-GDI
in vivo and luciferase assay in vitro, we demonstrate, for the first time, that Ly-GDI plays an
important regulatory role in acute lung inflammatory responses and injury.
Materials and Methods
Cells and Reagents
MH-S cells (CRL-2019™) and HEK 293 cells (CRL-1573™) were obtained from American Type
Culture Collection (Manassas, VA). MH-S cell were cultured in RPMI 1640 medium supple-
mented with 10% Fetal Bovine Serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin, and
0.01 M Hepes. HEK 293 cells were cultured in Eagle's Minimum Essential Medium containing
10% FBS, 2 mM L-glutamine, and 100 units/ml penicillin. They were maintained in a humidi-
fied incubator at 37°C with 5% CO2. ELISA kits for mouse IL-6, TNF-α, C5a, MCP-1, MIP-2,
MIP-1α, MIP-1β, and KC were purchased from R&D Systems (Minneapolis, MN). BSA and
Rabbit anti-BSA IgG were obtained from Sigma-Aldrich (St. Louis, MO), and ICN Biomedi-
cals, Inc. (Solon, OH), respectively.
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IgG IC-Induced Acute Lung Injury
All procedures involving mice were approved by the Animal Care and Use Committee of Har-
vard Medical School (approval number 04584) which accepts as mandatory the PHS Policy on
Humane Care and Use of Laboratory Animals by Awardee Institutions and NIH Principles for
the Utilization and Care of Vertebrate Animals Testing, Research, and Training. Eight-week
old specific pathogen-free male C57BL/6 mice were obtained from Jackson Laboratories (Bar
Harbor, ME). Mice were anesthetized intraperitoneally with ketamine HCl (100 μg/g), and IgG
immune complexes-mediated acute lung injury was induced as described previously [21].
Briefly, mice received intratracheal injection of 0.24 mg rabbit anti-BSA IgG in a volume of
40 μl phosphate buffered (pH 7.4) saline (PBS). Immediately after airway administration of
anti-BSA, 1 mg BSA dissolved in 200 μl PBS was injected intravenously. Negative control mice
received airway injection of anti-BSA. Unless otherwise indicated, 4 h after IgG IC administra-
tion, mice were exsanguinated, the pulmonary circulation flushed via the pulmonary artery
with 1 ml PBS and the lungs surgically dissected. Lungs were immediately frozen in liquid
nitrogen.
Expression Vectors and Promoter Reporters
Full-length mouse Ly-GDI cDNA was amplified from total RNA of the mouse lung using
reverse transcription-PCR (Invitrogen, Carlsbad, CA), sequenced, and inserted into pcDNA3.1
(+) (Invitrogen, Carlsbad, CA). Recombinant adenovirus containing mouse Ly-GDI (Adeno-
Ly-GDI) was constructed by using BD Adeno-XTM Expression System 1 (BD Biosciences,
Palo Alto, CA). To generate the virus, Adeno-Ly-GDI was digested with PacI and transfected
to HEK-293 cells according to the manufacturer's instructions. Recombinant adenoviruses
were purified by BD Adeno-X virus purification kit (BD Biosciences, Palo Alto, CA). The viral
stocks were tittered using Adeno-X Rapid Titer Kit (D Biosciences, Palo Alto, CA). The mouse
TNF-α and IL-6 luciferase constructs were kindly provided by Richard C. Schwartz (Michigan
State University). NF-κB promoter reporter was obtained from Promega.
Intratracheal Injection of Adenovirus
50 μl of Adeno-GFP (BD Biosciences) or Adeno-Ly-GDI (5×108 pfu/mouse) was injected into
mice through airway. 3 days later, lungs were harvested to determine expression of Ly-GDI, or
mice were used for IgG IC-stimulated acute lung inflammation.
Bronchial Alveolar Lavage (BAL) Fluid Collection, Total and Differential
White Blood Cell Counts, and Chemokine/Cytokine ELISAs
4 hours after initiation of the acute lung injury, the thorax was opened and 1 ml of ice-cold,
sterile PBS was instilled into the lung via a tracheal incision. The recovered lavage fluid (BAL)
was centrifuged at 450 x g for 6 minutes and the cell-free supernatants were stored at -20°C.
Cell pellets were resuspended in 1 ml of Hanks balanced salt solution (HBSS) containing 0.5%
bovine serum albumin (BSA) and differential cell analyses were performed by Diff-Quik-
stained cytospin preparations (Dade, Duedingen, Switzerland) counting a total of 300 cells per
slide in randomly selected high-powered fields. The supernatant was used for chemokine and
cytokine measurements by sandwich ELISA.
Myeloperoxidase (MPO) Activity
Mice were scarified, and lungs were lavaged and perfused via the right ventricle with 1 ml of
PBS. MPO activity was assessed as described previously [15, 16].
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Permeability Index
Fours hours after intratracheally administration of IgG IC, mice were exsanguinated, and the
thorax was opened. 1 ml of ice-cold PBS was injected via an intratracheal cannula. Cell-free
supernatants were obtained by centrifuging bronchoalveolar lavage (BAL) fluids at 3000 rpm
for 5 min. Mouse BSA level in BAL fluids was determined by ELISA (Bethyl Laboratories,
Montgomery, TX), and the permeability index was expressed as the ratio of the albumin in the
IgG IC-injured lungs versus that in the control-treated lungs of same type of mice.
Histological Assay
Fours hours after airway deposition of IgG IC, 0.6 ml of 10% buffered (pH 7.2) formalin was
injected intratracheally. The lungs were fixed in a 10% buffered formalin solution for morpho-
logical assay by tissue sectioning and staining with hematoxylin and eosin (H&E).
Luciferase Assay
Transient transfections were performed with 2×105 cells plated in 12-well plates by using
0.5 μg of DNA and 1.5 μl of Fugene16 Transfection Reagent in 48.5 μl of Opti-MEM I medium
(Invitrogen, CA). 48 h after transfection, the cells were either incubated with or without
100 μg/ml IgG IC for 4 h. Cell lysates were used to measure luciferase activity by using the
Dual-Luciferase Reporter Assay System (Promega, WI).
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear extracts of whole lung tissues were prepared as described previously [21, 22]. Briefly,
frozen lungs were homogenized in 0.6% (v/v) Nonidet P-40, 150 mMNaCl, 10 mMHEPES
(pH 7.9), 1 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 2.5 μg/ml leupeptin, 5 μg/ml
antipain, and 5 μg/ml aprotinin. The homogenate was incubated on ice for 5 min and then cen-
trifuged for 5 min at 5000 rpm at 4°C. Proteins were extracted from the pelleted nuclei by incu-
bation at 4°C with solution B (420 mMNaCl, 20 mMHEPES (pH 7.9), 1.2 mMMgCl2, 0.2
mM EDTA, 25% (v/v) glycerol, 0.5 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride,
2.5 μg/ml leupeptin, 5 μg/ml antipain, and 5 μg/ml aprotinin). Nuclear debris was pelleted by
centrifugation at 5000 rpm for 5 min at 4°C, and the supernatant extract was collected and
stored at -80°C. Protein concentrations were determined by Bio Rad protein assay using BSA
as a reference standard (Pierce Co.). The EMSA probes were double-stranded oligonucleotides
containing a NF-κB consensus oligonucleotide (AGTTGAGGGGACTTTCCCAGGC, Promega,
Madison, WI). NF-κB probes were labeled with γ [32P] ATP (3,000 Ci/mmol at 10 mCi/ml, GE
Healthcare, Piscataway, NJ). DNA binding reactions were performed at room temperature in a
25 μl reaction mixture containing 12 μg of nuclear extract and 5 μl of 5× binding buffer (20%
(w/v) Ficoll, 50 mMHEPES pH 7.9, 5 mM EDTA, 5 mM dithiothreitol). The remainder of the
reaction mixture contained KCl at a final concentration of 50 mM, Nonidet P-40 at a final con-
centration of 0.1%, 1 μg of poly (dI-dC), 200 pg of probe (unless otherwise noted), bromphenol
blue at a final concentration of 0.06% (w/v), and water to volume of 25 μl. Samples were elec-
trophoresed through 5.5% polyacrylamide gels in 1× TBE (90 mM Tris base, 90 mM boric acid,
0.5 mM EDTA) at 190 V for approximately 3.5 h, dried under vacuum, and exposed to X-ray
film.
RNA Isolation and Detection of mRNA by Real-Time PCR
Total RNAs were extracted from mouse lungs with Trizol (Invitrogen, CA) according to the
manufacturer’s procedure. After isolation, 2 μg of total RNA was subjected to reverse
Ly-GDI, Pulmonary, Immune Complex, Alveolitis
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transcription by using the Superscript II RNase H- Reverse Transcriptase (Invitrogen, CA).
The Ly-GDI mRNA level was investigated by real time PCR. PCR was performed with primers
for Ly-GDI: 5’ primer, 5’- GGA CTG GCA TGA GAG TGG AT -3’ and 3’ primer, 5’- AGG
TGA GGT GGT CCT GTT TG -3’. Following reverse transcription, the cDNA was amplified
and quantified using a Sequence Detection System (SDS 7300) and a PCR universal protocol as
follows: AmpliTaq Gold activation at 95°C for 15 s and, annealing/extension at 60°C for 1 min.
The fluorescence of the double-stranded products accumulated was monitored in real time.
The relative mRNA levels were normalized to levels of GAPDHmRNA in the same sample.
Western Blot Analysis
Mouse lungs were lysed in cold RIPA buffer. Samples containing 100 μg protein were electro-
phoresed in a 12% polyacrylamide gel and then transferred to a PVDF membrane. Membranes
were incubated with rabbit anti-Flag antibody (Abcam, MA), goat anti-Ly-GDI antibody
(Santa Cruz, CA), and rabbit anti-GAPDH antibody (Cell Signaling, MA), respectively. After 3
washes in TBST, the membranes were incubated with a 1:5,000 dilution of horseradish peroxi-
dase-conjugated donkey anti-rabbit IgG (GE Healthcare, Piscataway, NJ). The membrane was
developed by enhanced chemiluminescence technique according to the manufacturer’s proto-
col (Thermo Fisher Scientific, Rockford, IL).
Statistical Analysis
All values were expressed as the mean ± S. E. M. Data sets were analyzed using Student’s t test
or one-way ANOVA, with individual group means being compared with the Student-New-
man-Keuls multiple comparison test.
Results
Adenovirus-Mediated Ly-GDI Expression in the Lung Attenuates IgG
IC-Induced Lung Injury
A recent report shows that Ly-GDI expression significantly inhibits FcγR-mediated phagocyto-
sis [1], however, its role in inflammation mediated by FcγR activation is unknown. We deter-
mined Ly-GDI expression in IgG IC-injured lung. As shown in Fig 1, lung Ly-GDI expression
assessed by real-time PCR (Fig 1A) andWestern blot (Fig 1B) was significantly decreased 4 h
after IgG IC deposition in the lung. To evaluate the role of Ly-GDI in FcγR-mediated acute
lung inflammation, we constructed recombinant adenovirus which could express Ly-GDI with
a Flag tag in its N-terminal region (Adeno-Ly-GDI). In vitro experiment demonstrated that
Ly-GDI expression was dramatically elevated in HEK293 cells infected by Adeno-Ly-GDI
when compared with cells incubated with control virus (Adeno-GFP, Fig 2A). To further deter-
mine if Adeno-Ly-GDI could mediate Ly-GDI expression in mouse lungs, we intratracheally
administrated different doses of Adeno-Ly-GDI (2.5×108 and 5 × 108 PFU) into mouse lung.
72 h later, whole lung homogenates were used to performWestern blot to examine Ly-GDI
expression. As shown in Fig 2B, adenovirus-mediated Ly-GDI expression was evident at a dose
of 5×108 PFU, and no strong Ly-GDI expression could not be observed in Adeno-GFP- and
low dose Adeno-Ly-GDI-infected mouse lungs.
Next, we sought to determine the role of Ly-GDI in IgG IC-induced acute lung inflamma-
tion. 4 h after alveolar deposition of IgG IC, cell-free BAL fluids were harvested. Mouse albu-
min level in the BAL fluids was measured by ELISA, and permeability index was expressed as a
ratio of total albumin in BAL fluid obtained from the inflamed lung to an average albumin con-
tent of the corresponding control group. We found that IgG IC treatment resulted in a marked
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increase in permeability index (Fig 2C). Notably, permeability index was greatly reduced in
mice receiving airway administration of Adeno-Ly-GDI when compared with mice that
received Adeno-GFP (69%, p<0.001, Fig 2C). Next, we measured lung MPO activity, which is
a marker for neutrophil accumulation. As shown in Fig 2D, MPO activity in IgG IC-injured
lung was dramatically elevated compared with that of control mice receiving anti-BSA only.
Consistent with permeability index, IgG IC-induced lung MPO activity was significantly lower
in mice receiving Adeno-Ly-GDI when compared with control counterparts receiving Adeno-
GFP (32%, p<0.01, Fig 2D). These data together indicate that Ly-GDI suppressed pulmonary
capillary leakage and neutrophil recruitment during IgG IC-induced acute lung injury.
We further examined if mice that received intratracheal administration of Adeno-Ly-GDI
exhibited attenuated lung injury by histological assay. We observed that airway injection of
Adeno-GFP or Adeno-Ly-GDI had no influence on pulmonary inflammation and normal lung
architecture (Fig 3A and 3C). Mice received Adeno-Ly-GDI together with IgG IC exhibited
lung edema, hemorrhage, and neutrophil accumulation (Fig 3B). In contrast, all of these fea-
tures were greatly attenuated in mice receiving Adeno-Ly-GDI during IgG IC-induced acute
lung inflammation (Fig 3D).
IgG IC-Induced Leukocyte Accumulation in the Alveoli Is Decreased by
Ly-GDI
We determined the total leukocyte and neutrophil contents in BAL fluids. As shown in Fig 4A
and 4h after IgG IC deposition in the lung, the number of leukocytes present in BAL fluids was
significantly increased as compared with control mice challenged with anti-BSA alone. In
injured lungs, the major cells recovered from BAL fluids were neutrophils (Fig 4). Importantly,
we found that in the presence of IgG IC, mice receiving Adeno-Ly-GDI showed a significant
decrease of total leukocytes and neutrophil accumulation in airspaces when compared with
control mice receiving Adeno-GFP (40%, p<0.001 and 39%, p<0.001, respectively, Fig 4).
Fig 1. Ly-GDI expression in the lung is decreased by IgG immune complex challenge. (A) Whole lung
RNAs were extracted 4 h after pulmonary deposition of IgG immune complexes, and subjected to reverse
transcription. Real-time PCR was performed to examine the expression of Ly-GDI and GAPDH. Data were
expressed as means ± S. E. M. N = 4 mice for each group. * indicated statistically significant difference-
p < 0.05. (B) Total proteins obtained from control or IgG immune complex-challenged lungs were subjected to
Western blot by using goat anti-Ly-GDI antibodies. The level of GAPDHwas shown at the bottom as a
loading control.
doi:10.1371/journal.pone.0140804.g001
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Thus, Ly-GDI inhibited migration of leukocytes, especially neutrophils into the alveoli in IgG
IC-injured mice.
Ly-GDI Regulates Cytokine and Chemokine Expression in the Lung
Challenged by IgG IC
We evaluated the role of Ly-GDI expression in inflammatory cytokine and chemokine genera-
tion in BAL fluids 4 h after pulmonary deposition of IgG IC. As shown in Fig 5, intratracheal
administration of adenovirus alone without IgG IC challenge could not induce an increase in
the levels of the indicated proinflammatory mediators. BAL fluids from IgG IC-injured mice
receiving Adeno-GFP or Adeno-Ly-GDI exhibited dramatically augmented expressions of
TNF-α, IL-6, and CC chemokines-MCP-1 and MIP-1α (Fig 5). Moreover, in IgG IC-injured
Fig 2. Over-expression of Ly-GDI mitigates IgG immune complex-induced acute lung injury. (A) HEK
293 cells were infected with Adeno-GFP and Adeno-Ly-GDI (with a Flag tag in N-terminal), respectively.
When cytopathic effect became evident, the infected cells were lysed by using RIPA buffer. (B) Mice received
intratracheal injection of Adeno-GFP or Adeno-Ly-GDI at the indicated doses. 3 days later, whole lung
proteins were extracted by using RIPA buffer. Total proteins obtained from adenovirus-infected HEK 293
cells or mouse lungs were subjected to Western blot by using rabbit anti-Flag antibodies. The level of GAPDH
was shown at the bottom as a loading control. (C and D) Adeno-GFP or Adeno-Ly-GDI was injected to mice
via an airway instillation at a dose of 5 × 108 PFU. 3 days later, the mice were subjected to IgG immune
complex-induced lung injury or control treatment (αBSA only). Mouse albumin levels (C) in BAL fluids were
measured 4 h later, and the permeability index was expressed as the ratio of the albumin in the IgG immune
complex-injured lungs versus that in the control-treated lungs of same type of mice. Lung MPO activity (D)
was evaluated, and used as a marker for pulmonary neutrophil accumulation. Data were expressed as
means ± S. E. M. N 3 mice for each group. ** and *** indicated statistically significant difference-p < 0.01
and p < 0.001, respectively.
doi:10.1371/journal.pone.0140804.g002
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lungs, ectopic expression of Ly-GDI led to a significant reduced production of TNF-α, IL-6,
MCP-1, and MIP-1α (by 51%, 68%, 71%, and 44%, respectively) when compared with mice
receiving airway administration of Adeno-GFP (Fig 5). However, there was no statistical differ-
ence in MIP-1β, KC, and MIP-2 production between Adeno-GFP-treated mice and Adeno-Ly-
Fig 3. Histologically, Ly-GDI expression attenuates IgG immune complex-induced acute lung
inflammation. Adeno-GFP or Adeno-Ly-GDI was injected to mice via an airway instillation at a dose of
5 × 108 PFU. 3 days later, the mice were subjected to IgG immune complex-induced lung injury or control
treatment (αBSA only). Lungs were harvested 4 h later, and lung sections were stained with H & E
(40 × magnification). Lung sections shown included: Adno-GFP + anti-BSA (A), Adeno-GFP + IgG IC (B),
Adeno-Ly-GDI + anti-BSA (C), and Adeno-Ly-GDI + IgG IC (D). Scale bar, 60 μm.
doi:10.1371/journal.pone.0140804.g003
Fig 4. Over-expression of Ly-GDI reduces IgG immune complex-stimulated leukocytes accumulation
in alveoli. Adeno-GFP or Adeno-Ly-GDI was injected to mice via an airway instillation at a dose of 5 × 108
PFU. 3 days later, the mice were subjected to IgG immune complex-induced lung injury or control treatment
(αBSA only). Total leukocytes (A) and neutrophils (B) in BAL fluids were counted 4 h later. Data were
expressed as means ± S. E. M. N 3 mice for each group. *** indicated statistically significant difference-
p < 0.001.
doi:10.1371/journal.pone.0140804.g004
Ly-GDI, Pulmonary, Immune Complex, Alveolitis
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Fig 5. Over-expression of Ly-GDI decreases IgG immune complex-induced generation of pro-inflammatory mediators in BAL fluids. (A-D) Adeno-
GFP or Adeno-Ly-GDI was injected to mice via an airway instillation at a dose of 5 × 108 PFU. 3 days later, the mice were subjected to IgG immune complex-
induced lung injury or control treatment (αBSA only). Cell-free BAL fluids were harvested 4 h later, and ELISAs were conducted to measure the TNF-α (A), IL-
6 (B), MCP-1 (C), and MIP-1α (D) levels. (E and F)MH-S cells were transiently transfected with indicated genes. 48 h later, the cells were treated with or
without 100 μg/ml IgG immune complexes for 4 h. The cell lysates were used to evaluate luciferase expression. Luminometer values were normalized for
Ly-GDI, Pulmonary, Immune Complex, Alveolitis
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GDI-treaed mice in the presence of IgG IC (data not shown). These data suggest that Ly-GDI
selectively inhibited certain pro-inflammatory mediators’ production during IgG IC-induced
acute lung injury.
To further determine the effect of Ly-GDI on IgG IC-stimulated inflammation, we assessed
whether Ly-GDI affected luciferase expressions controlled by IL-6 promoter and TNF-α pro-
moter, respectively, in alveolar macrophage, MH-S cells, incubated in the presence or absence
of IgG IC. As shown in Fig 5E and 5F, both IL-6- and TNF-luciferase expression were signifi-
cantly augmented by IgG IC stimulation. Notably, over-expression of Ly-GDI dramatically
suppressed the IgG IC-induced luciferase activities in MH-S cells.
Ly-GDI Plays a Negative Role in C5a Level in BAL Fluids Recovered
from IgG IC-Injured Lungs
Previous study has shown that C5a is required for the full production of TNF-α, pulmonary
neutrophil accumulation, and lung injury in IgG IC-induced acute lung inflammation model
[19]. Therefore, we sought to elucidate whether C5a level in BAL fluids could be regulated by
Ly-GDI. We found that Adeno-Ly-GDI alone without IgG IC treatment resulted in a moderate
increase in the BAL fluid C5a level as compared with Adeno-GFP treatment, but there was no
statistical difference (Fig 6). Moreover, there was a significant increase in C5a content in BAL
fluids obtained from IgG IC-inflamed lungs (Fig 6). Notably, in the presence of IgG IC deposi-
tion, Adeno-Ly-GDI mice showed a significantly reduced C5a level in BAL fluids when com-
pared with Adeno-GFP mice (Fig 6).
Ly-GDI Inhibits IgG IC-Induced NF-κB Activity in the Lung and Alveolar
Macrophages
We sought to determine the potential mechanism by which Ly-GDI mitigated IgG-IC-induced
inflammation in the lung. We infected mice with Adeno-GFP or Adeno-Ly-GDI by airway
injection. 3 d later, the mice were challenged with or without IgG IC for 4 h, and the whole
lung nuclear extracts were subjected to EMSA. As shown in Fig 7A, IgG IC significantly
induced NF-κB DNA binding activity when compared with anti-BSA challenge alone. Notably,
the amount of lung NF-κB associated with its consensus sequence was markedly reduced in
IgG IC-inflamed mice receiving airway administration of Adeno-Ly-GDI when compared with
their littermates intratracheally injected with Adeno-GFP (Fig 7A). Alveolar macrophages con-
tributed to full activation of NF-κB in IgG IC-induced acute lung inflammation model [23]. To
elucidate the role of Ly-GDI in IgG IC-induced NF-κB activation in alveolar macrophages, we
performed in vitro luciferase experiments by using MH-S cells. As shown in Fig 7B, IgG IC
treatment led to an over 5-fold increase of luciferase production driven by NF-κB, and over-
expression of Ly-GDI caused a significant decrease of luciferase expression in MH-S cells.
Discussion
Ly-GDI suppresses the activation of small GTPases of the Rho family by inhibiting dissociation
of GDP from Rho proteins. Although the Rho family plays critical roles in inflammatory signal
transduction cascades, however, the function of Ly-GDI in immune system remains largely
unknown. Ly-GDI was originally identified as a metastasis suppressor in bladder cancer during
expression from a co-transfected thymidine kinase reporter gene. These values were also normalized to a relative value of 1 for the control plasmid-
transfected cells that did not receive IgG immune complex stimulation. Data were expressed as means ± S. E. M. N 3 mice for each group. *, ** and ***
indicated statistically significant difference- p<0.05, p < 0.01 and p < 0.001, respectively.
doi:10.1371/journal.pone.0140804.g005
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studies of the differential invasive and metastatic properties of isogenic human bladder carci-
noma cell lines [24]. Using Ly-GDI knock-out mice, Yin et al show that Ly-GDI is not essential
for development of the immune system or many immunological functions, but significantly
influences lymphocyte growth and survival during in vitro cultivation [25]. In addition, Ly-
GDI associates with CARD9, a caspase-recruitment domain (CARD)-containing protein, in
phagosomes after bacterial and fungal infection, and binding of CARD9 suppressed LyGDI-
mediated inhibition of the GTPase Rac1, thereby leading to bacterial killing in macrophages
[26]. Ectopic expression of Ly-GDI greatly inhibited FcγR-mediated phagocytosis in human
monocytes, but its role in FcγR activation-triggered inflammatory reactions was still unknown
[1]. In the current report, we show that Ly-GDI expression was significantly reduced in lungs
during IgG IC-induced ALI. Importantly, Ly-GDI plays a negative role in IgG IC-induced
inflammatory responses in the lung and alveolar macrophages.
During IgG IC-induced ALI, alveolar macrophages are activated, and play a critical role in
IgG IC-stimulated generation of pro-inflammatory mediators including a variety of chemo-
kines and cytokines [27]. For example, production of TNF-α that is considered as an early
response cytokine was dramatically increased in IgG IC-injured lungs, which contributed to
the elevated synthesis of chemokines such as MIP-1α, and final pulmonary injury including
increased lung microvascular permeability, neutrophil accumulation, and pulmonary hemor-
rhage [17, 19, 20, 28, 29]. MIP-1α belongs to CC chemokine family, and is required for forma-
tion of chemoattractant gradients and subsequent transmigration of polymorphonuclear
neutrophils (PMNs) from vascular vessels into lungs [30]. MCP-1 is also a member of CC che-
mokine family, and plays an essential role in regulating macrophage infiltration. Our finding
that over-expression of Ly-GDI led to a decreased expression of various pro-inflammatory
mediators including TNF-α, IL-6, MCP-1, and MIP-1α suggests that Ly-GDI regulates IgG IC-
Fig 6. Ly-GDI over-expression leads to reduced IgG immune complex-induced production of C5a in
BAL fluids. Adeno-GFP or Adeno-Ly-GDI was injected to mice via an airway instillation at a dose of 5 × 108
PFU. 3 days later, the mice were subjected to IgG immune complex-induced lung injury or control treatment
(αBSA only). Cell-free BAL fluids were harvested 4 h later, and ELISA was conducted to measure the C5a
content. Data were expressed as means ± S. E. M. N 3 mice for each group. * indicated statistically
significant difference- p < 0.05.
doi:10.1371/journal.pone.0140804.g006
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induced ALI by cytokine and chemokine pathways. In addition, the reduced MCP-1 produc-
tion may contribute to decreased accumulation of macrophages in lungs, which further leads
to inhibition of IgG IC-induced lung inflammation and injury. Interestingly, a recent study
implicates that Ly-GDI suppresses cancer metastasis by reducing MCP-1 expression in tumor
microenvironment, which was required for macrophage infiltration [31].
The molecular mechanism by which Ly-GDI affects cytokine and chemokine gene expres-
sion is not clear. RhoA, Rac, and Cdc42 all participate in the signaling pathways required for
the activity of NF-κB, leading to the induction of cytokines and chemokines [32, 33]. Further-
more, the activation of NF-κB has been linked to Rho-dependent activation of the c-Jun
NH2-terminal kinase/stress-activated protein kinase pathway [32, 34]. Our current study
shows that Ly-GDI reduces the activation of both lung NF-κB (Fig 7) and Stat3 (data not
shown). These two transcription factors are important regulators of inflammatory mediators.
Thus, it is possible that Ly-GDI mitigates IgG IC-induced cytokine and chemokine expression
by regulating NF-κB and Stat3 activity in the lung. However, the detailed pathways for this reg-
ulation remain to be determined.
Another interesting finding in this study is that C5a generation in BAL fluids was signifi-
cantly reduced in mice receiving Adeno-Ly-GDI when compared with control mice treated
with Adeno-GFP during IgG IC-induced ALI. Our previous studies showed that pulmonary
STAT3 was activated after airway deposition of IgG IC, which positively regulated IgG IC-
induced acute pulmonary inflammation [15, 18]. In addition, STAT3 activation was dependent
Fig 7. Ly-GDI inhibits IgG immune complex-induced NF-κB activity in the lung and alveolar
macrophages. (A) Adeno-GFP or Adeno-Ly-GDI was injected to mice via an airway instillation at a dose of
5 × 108 PFU. 3 days later, the mice were subjected to IgG immune complex-induced lung injury or control
treatment (αBSA only). Lungs were harvested 4 h later. Whole lung nuclear proteins were extracted, and
subjected to EMSA to determine the NF-κB DNA binding activity. (B)MH-S cells were transiently transfected
with indicated genes. 48 h later, the cells were treated with or without 100 μg/ml IgG immune complexes for 4
h. The cell lysates were used to evaluate luciferase expression. Luminometer values were normalized for
expression from a co-transfected thymidine kinase reporter gene. These values were then normalized to a
relative value of 1 for the control plasmid transfected cells that did not receive IgG IC challenge. The data
were expressed as means ± S. E. M. N = 3. * and *** indicated statistically significant difference-p < 0.05,
and p < 0.001, respectively.
doi:10.1371/journal.pone.0140804.g007
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on C5a/C5aR signaling pathway in lungs challenged by IgG IC [15]. Thus, Ly-GDI-mediated
C5a reduction may lead to STAT3 inhibition in IgG IC-injured lung.
Fcγ receptors (FcγRs), which bind to the Fc portion of IgG and induce inflammatory reac-
tions, play essential roles in immune defense system. The roles of FcγRs in IgG IC-induced
autoimmune diseases are extensively investigated, but growing evidences suggest that they also
play an important role in the regulation of innate immunity. For example, it was recently
shown that binding of IgG IC that is formed by interaction between peptidoglycan (PGN) and
the corresponding IgG antibody to FcγRIIA was indispensible for PGN-stimulated inflamma-
tion [35]. Because PGN is a major structural component of Gram-positive bacteria, these data
suggest that FcγRIIA may be involved in Gram-positive bacteria-mediated systemic inflamma-
tory responses [35]. This is supported by the finding that high expression of FcγRIIA on
human neutrophils is a sepsis biomarker [36, 37]. Moreover, there may be a crosstalk between
FcγRs and Toll-like receptors (TLRs) signaling pathways. For example, IgG IC could stimulate
interaction between TLR4 and FcγRIII, and disruption of the association by knockout or muta-
tion of TLR4 led to decreased inflammatory responses triggered by IgG IC [38]. Interestingly,
TLR4-induced TRIF-dependent pathway was positively regulated by FcγIIA, whereas
TLR4-triggered MyD88-dependent signaling pathway was suppressed by FcγIIA in human
monocytes [39]. Here, we showed that over-expression of Ly-GDI resulted in inhibition of IgG
IC-induced NF-κB transcriptional activity; however, whether Ly-GDI could regulate TRIF/
MyD88 pathways or suppress the interaction between TLR4 and FcγRs to affect NF-κB
remains an open question. Taken together, these studies and our current finding that Ly-GDI
is an important regulator of lung inflammatory injury after deposition of IgG IC may help to
understand a new signaling pathway which is important for both inflammation/infection and
autoimmune diseases.
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